Charcot-Marie-Tooth neuropathy type 2S (CMT2S) is a rare inherited nerve disease that mainly damages the long nerves in the arms and legs. It is an “axonal” form of Charcot-Marie-Tooth (CMT), which means the main problem is with the central part (axon) of the nerve fiber rather than the myelin coating. Over time, this damage causes weakness and thinning (wasting) of muscles in the feet, legs, hands, and sometimes arms, along with reduced sensation. GARD Information Center+1
Charcot-Marie-Tooth neuropathy type 2S (CMT2S) is a rare genetic nerve disease. It mainly damages the “axons,” which are the long wires of the peripheral nerves in the arms and legs. In most people it is caused by changes (mutations) in a gene called IGHMBP2. This gene helps motor neurons and sensory neurons stay healthy. When the gene does not work well, the distal nerves slowly fail, especially in the feet and hands.Frontiers+2National Organization for Rare Disorders+2
CMT2S usually starts in childhood or the teenage years. Children may learn to walk later, tire easily, or seem clumsy. As the disease slowly gets worse, people can develop foot drop, high-arched feet, difficulty with fine hand tasks, and sometimes need walking aids or a wheelchair in adult life. Despite this, many people have a normal life span, and the condition usually progresses slowly. GARD Information Center+2Charcot-Marie-Tooth Association+2
CMT2S is caused by harmful changes (mutations) in a gene called IGHMBP2. This gene helps nerve cells keep their structure and function. When both copies of this gene (one from each parent) are faulty, the motor and sensory nerves gradually fail, leading to the clinical picture of CMT2S. This pattern is called autosomal recessive inheritance. Frontiers+2IJ Case Reports and Images+2
Other names
Doctors and researchers may use several different names for CMT2S. One common name is “Charcot-Marie-Tooth disease, axonal, type 2S.” This highlights that it belongs to the group of axonal (type 2) CMT disorders. GARD Information Center+1
Another name is “CMT2S”, which is just the short code used in medical papers and gene databases. Sometimes it is also called “Charcot-Marie-Tooth disease caused by IGHMBP2 mutations”, because this gene change is the key cause of the condition. National Organization for Rare Disorders+2PubMed+2
More generally, CMT2S is part of the family of disorders known as “hereditary motor and sensory neuropathy (HMSN)” or “peroneal muscular atrophy.” These older names describe diseases that cause progressive weakness and wasting of muscles in the lower legs and feet, and later in the hands, due to inherited nerve damage. nhs.uk+2Wikipedia+2
Types of Charcot-Marie-Tooth neuropathy type 2S
Although CMT2S is one genetic subtype, people can show different clinical patterns. One pattern is early-childhood onset CMT2S, where babies or toddlers have floppy muscles (hypotonia), delayed motor milestones (late sitting or walking), and early foot deformities. These children may need physical therapy, braces, and sometimes early orthopedic care. GARD Information Center+2Charcot-Marie-Tooth Association+2
A second pattern is juvenile-onset CMT2S, starting in school age or the teenage years. These children often present with tripping, difficulty running, frequent ankle sprains, and slowly progressing weakness in the feet and legs. Hand weakness and fine motor difficulties usually appear later. GARD Information Center+2Mayo Clinic+2
A third pattern is CMT2S with autonomic and skeletal involvement, where the classic motor and sensory symptoms are accompanied by scoliosis (curved spine) and mild autonomic problems, such as abnormal sweating or changes in heart rate and blood pressure. These features reflect broader nerve system involvement beyond simple limb weakness and numbness. GARD Information Center+2MalaCards+2
Causes of Charcot-Marie-Tooth neuropathy type 2S
IGHMBP2 gene mutation (primary cause)
The main cause of CMT2S is a harmful mutation in both copies of the IGHMBP2 gene. This gene codes for a protein important for nerve cell survival and RNA/DNA handling. When it does not work properly, the long axons of motor and sensory nerves gradually degenerate, leading to weakness and sensory loss. Frontiers+2PubMed+2Autosomal recessive inheritance
CMT2S follows an autosomal recessive pattern. This means a person must inherit one faulty IGHMBP2 copy from each parent. Parents are usually “carriers” with one normal and one mutated copy and often have no symptoms. When two carriers have a child, there is a 25% chance the child will have CMT2S. IJ Case Reports and Images+2National Organization for Rare Disorders+2Consanguinity (parents being related)
In some families, parents are related (for example, cousins). This increases the chance that both parents carry the same rare IGHMBP2 mutation, raising the likelihood that their children can inherit two faulty copies and develop CMT2S. ScienceDirect+2Charcot-Marie-Tooth Association+2Loss of IGHMBP2 protein function
Many CMT2S mutations cause the IGHMBP2 protein to be shorter, unstable, or non-functional. This functional loss means nerve cells cannot correctly process nucleic acids and maintain axonal health, which over time leads to peripheral neuropathy. Frontiers+1Axonal degeneration of peripheral nerves
CMT2S belongs to CMT type 2, the axonal form of the disease. Axonal degeneration means the central cable of the nerve fiber slowly breaks down. This process interrupts signal transmission between the spinal cord and the muscles or skin, causing weakness and sensory loss. MDPI+2Muscular Dystrophy Association+2Distal motor neuron vulnerability
The longest motor neurons, especially those going to the feet and hands, are most vulnerable to damage in CMT2S. Their great length makes them more dependent on proper axonal transport and metabolic support, which are disturbed when IGHMBP2 is not working well. Semantic Scholar+2MDPI+2Impaired RNA/DNA metabolism in neurons
IGHMBP2 is a helicase-like protein involved in handling DNA and RNA in cells. Mutations may disturb these processes in neurons, damaging the machinery needed for protein synthesis and repair and contributing to nerve degeneration in CMT2S. Frontiers+1Disrupted maintenance of myelinated axons
Although CMT2S is primarily axonal, healthy communication between axons and their myelin-forming cells is essential. Faulty IGHMBP2 can indirectly affect how nerves and Schwann cells interact, worsening axonal degeneration and clinical symptoms. MDPI+1Shared pathways with SMARD1
IGHMBP2 mutations can also cause another condition called spinal muscular atrophy with respiratory distress type 1 (SMARD1). Overlap of molecular pathways between CMT2S and SMARD1 suggests that motor neuron survival pathways are deeply affected, contributing to neuropathy in CMT2S. Frontiers+1Family history of CMT or related neuropathies
Having relatives with CMT2S, other CMT types, or SMARD1 increases the chance that IGHMBP2 mutations run in the family. This family history is a strong clue that inherited gene changes, rather than acquired factors, are the main cause. Charcot-Marie-Tooth Association+2Northwestern Medicine+2De novo mutation (new mutation in the egg or sperm)
In some rare cases, a new IGHMBP2 mutation may appear for the first time in a child, even if parents are not known carriers. This “de novo” event can still produce CMT2S if the child ends up with two affected copies (for example, one inherited and one new mutation). Charcot-Marie-Tooth Association+1Mitochondrial stress in peripheral nerves
Studies of axonal CMT suggest that impaired axonal transport and energy supply from mitochondria contribute to nerve degeneration. In CMT2S, IGHMBP2 dysfunction may further stress mitochondrial function, making long axons more likely to fail. MDPI+1Impaired axonal transport
Axonal transport moves nutrients and cellular materials along the nerve fiber. In axonal CMT, this system is often impaired, so distal segments of the nerve do not receive enough support. In CMT2S, IGHMBP2-related damage may worsen these transport problems. MDPI+1Chronic denervation of distal muscles
As motor axons degenerate, muscles at the ends of the limbs lose their nerve supply, a process called denervation. Chronic denervation leads to muscle wasting and weakness, especially in the feet, lower legs, hands, and forearms, which is typical of CMT2S. GARD Information Center+2Muscular Dystrophy Association+2Secondary skeletal deformities
Persistent muscle imbalance around joints, caused by nerve damage, results in secondary deformities such as pes cavus (high-arched feet), hammertoes, and scoliosis. While these deformities do not cause CMT2S, they are a direct consequence of the underlying neuropathy and can worsen disability. GARD Information Center+2nhs.uk+2Autonomic nerve involvement
Some CMT2S patients show autonomic symptoms such as abnormal sweating, cold extremities, or heart rate changes. These signs reflect involvement of small autonomic fibers, again due to IGHMBP2-related nerve damage, and contribute to the overall clinical picture. GARD Information Center+1Modifier genes
Different people with the same IGHMBP2 mutation can show different disease severity. This suggests that other genes in the body may modify how strongly the CMT2S mutation expresses itself, making symptoms milder or more severe. MDPI+1Environmental stress on already weak nerves
While CMT2S is genetic, factors such as poor nutrition, uncontrolled diabetes, toxins, or repeated nerve compression may worsen symptoms in already vulnerable nerves. These factors do not cause CMT2S alone but can increase nerve damage in affected individuals. Hospital for Special Surgery+1Age-related nerve degeneration
As people age, nerves naturally lose some function. In someone with CMT2S, this normal age-related decline adds on top of the genetic vulnerability, leading to further progression of weakness and sensory loss over decades. MDPI+1Lack of nerve regeneration capacity
Human peripheral nerves have limited ability to repair long-standing axonal damage. In CMT2S, continuous damage from IGHMBP2 mutation overwhelms any natural repair, so nerve function gradually declines and symptoms accumulate over time. MDPI+1
Symptoms of Charcot-Marie-Tooth neuropathy type 2S
Progressive weakness in feet and lower legs
The most common early symptom is slowly increasing weakness in the feet and lower legs. People may struggle to run, climb stairs, or stand on their toes. This happens because the motor nerves that control these muscles are damaged and cannot send strong signals. Mayo Clinic+2GARD Information Center+2Foot drop and tripping
Weakness in the muscles that lift the front of the foot causes foot drop. The toes drag during walking, so the person may trip often and adopt a “steppage” gait, lifting the knees higher than normal to clear the ground. Mayo Clinic+2nhs.uk+2High-arched feet (pes cavus) and hammertoes
Over time, muscle imbalance around the foot causes the arch to become very high and the toes to bend like claws (hammertoes). These deformities can cause pain, shoe-fitting problems, and pressure sores. They are classic signs of inherited neuropathies like CMT2S. GARD Information Center+2nhs.uk+2Muscle wasting in legs and later in hands
As nerves die back, the muscles they supply shrink, giving the legs a “stork-like” or “inverted champagne bottle” shape. Later, hand muscles can also waste, making the hands look thin and bony. GARD Information Center+2Mayo Clinic+2Weakness in hands and forearms
Hand weakness often appears after leg symptoms. People may have trouble buttoning clothes, writing, using tools, or holding small objects. This reflects involvement of motor nerves to the intrinsic hand muscles and finger extensors. Hopkins Medicine+2Cleveland Clinic+2Numbness and reduced feeling in feet and hands
Sensory nerves are also affected. Patients may notice numbness, tingling, or “pins and needles” in the toes and fingertips. They might not feel pain, temperature, or light touch as clearly as before, especially in the distal parts of limbs. Mayo Clinic+2GARD Information Center+2Poor balance and unsteady walking
Loss of position sense in the feet and weakness of ankle muscles make balance difficult, especially in the dark or on uneven ground. People may appear clumsy, sway when standing, or feel insecure when walking without support. Mayo Clinic+2nhs.uk+2Decreased or absent tendon reflexes
Many people with CMT2S have very weak or absent ankle and knee reflexes when tested with a reflex hammer. This finding reflects damage to the reflex arc in the peripheral nerves and is a key clinical sign of axonal neuropathy. GARD Information Center+2MalaCards+2Muscle cramps and fatigue
Damaged nerves may fire abnormally or fail to coordinate muscle activity, leading to painful cramps in the legs or feet. Everyday activities can cause tiredness and muscle fatigue faster than in healthy people, because fewer motor units are working. Cleveland Clinic+2Hopkins Medicine+2Neuropathic pain or burning sensations
Some patients experience burning, stabbing, or electric-shock-like pain in the feet and legs. This neuropathic pain comes from damaged sensory nerves sending abnormal signals to the brain. Not everyone has pain, but it can be disabling when present. Cleveland Clinic+2Hospital for Special Surgery+2Scoliosis and posture problems
Weakness and imbalance of trunk and paraspinal muscles can cause scoliosis (a sideways curvature of the spine) and poor posture. This can lead to back pain and may require bracing or surgery in severe cases. GARD Information Center+2MalaCards+2Fine motor difficulties
Because of hand weakness and sensory loss, tasks such as tying shoelaces, zipping, typing, or drawing become difficult. Children may be slow with school tasks that require good hand control, and adults may struggle with detailed manual work. Hopkins Medicine+2Cleveland Clinic+2Frequent ankle sprains and joint instability
Weak ankle muscles and reduced sensation make the ankle unstable. People often twist their ankles and suffer repeated sprains. Over time, this can cause chronic joint pain and further limit mobility. Mayo Clinic+2nhs.uk+2Autonomic symptoms (sweating, temperature changes)
Some patients report cold, pale feet, abnormal sweating, or intolerance to heat. These problems suggest mild involvement of autonomic nerves, which control blood flow and sweat glands in the skin. GARD Information Center+2MalaCards+2Loss of mobility and need for walking aids or wheelchair
In more severe or advanced CMT2S, leg weakness and deformities may lead to falls and difficulty walking even short distances. Many people use ankle-foot orthoses (AFOs), canes, or walkers, and some may eventually rely on a wheelchair for long distances. GARD Information Center+2Charcot-Marie-Tooth Association+2
Diagnostic tests for Charcot-Marie-Tooth neuropathy type 2S
Physical exam
Complete neurological examination
The neurologist starts with a full neurological exam, checking muscle strength, tone, reflexes, sensation, and coordination in all limbs. The pattern of distal weakness, reduced reflexes, and length-dependent sensory loss suggests peripheral neuropathy, such as CMT2S, rather than spinal cord or brain disease. Hopkins Medicine+2Northwestern Medicine+2Gait and posture observation
The doctor watches how the person walks, stands, and turns. A high-stepping gait, foot drop, frequent tripping, and difficulty walking on heels or toes are characteristic of CMT. Observation can also show scoliosis or poor posture related to trunk muscle weakness. Mayo Clinic+2nhs.uk+2Examination of feet, legs, hands, and spine
The feet and legs are examined for high arches, hammertoes, thin calves, and ankle instability. The hands are examined for wasting of small muscles and weakness. The spine is checked for scoliosis. These structural changes support a chronic inherited neuropathy like CMT2S. GARD Information Center+2MalaCards+2Autonomic examination
Blood pressure, heart rate, skin color, sweating, and temperature of the limbs are assessed. If there are signs of autonomic dysfunction, such as abnormal blood pressure changes on standing or altered sweating, they suggest more widespread peripheral nerve involvement. MalaCards+2MalaCards+2
Manual tests
Manual muscle testing (MMT)
The doctor tests each major muscle group by asking the patient to push or pull against resistance. Strength is graded on a standard scale. CMT2S typically shows stronger muscles near the trunk and weaker muscles at the distal parts of the arms and legs. Hopkins Medicine+2MDPI+2Manual sensory testing
Light touch (cotton), pinprick, vibration (tuning fork), and joint position sense are tested at different points on the limbs. A “glove and stocking” pattern of reduced sensation in the feet and hands supports a diagnosis of length-dependent peripheral neuropathy. Mayo Clinic+2Cleveland Clinic+2Deep tendon reflex testing
Reflexes at the ankles, knees, elbows, and wrists are tested using a reflex hammer. In CMT2S, ankle reflexes are often absent and knee reflexes may be reduced or absent. This pattern is typical of peripheral neuropathy, especially axonal forms. GARD Information Center+2MalaCards+2Balance and coordination tests (Romberg and heel-toe walking)
Simple bedside tests, such as standing with feet together and eyes closed (Romberg test) or walking heel-to-toe in a straight line, help assess balance and coordination. Worsening sway with eyes closed and difficulty with heel-toe walking point toward sensory and motor nerve problems. Hopkins Medicine+2MDPI+2
Lab and pathological tests
Basic blood tests to rule out other neuropathies
Blood tests for blood sugar, vitamin B12, folate, thyroid, kidney and liver function, and sometimes autoimmune markers are done to exclude common acquired causes of neuropathy. Normal results make an inherited cause like CMT2S more likely. Hospital for Special Surgery+2Cleveland Clinic+2Comprehensive CMT genetic testing panel
Many centers use multi-gene panels that test dozens of CMT-related genes at once. This approach increases the chance of identifying the exact subtype, including CMT2S, and helps separate it from other genetic neuropathies. Northwestern Medicine+2Charcot-Marie-Tooth Association+2Targeted IGHMBP2 gene sequencing
When CMT2S is suspected, or when a panel suggests changes in IGHMBP2, targeted sequencing of this gene is done to confirm mutations in both copies. Finding disease-causing variants in IGHMBP2 is the gold standard for diagnosing CMT2S. Frontiers+2PubMed+2Carrier testing for family members
Once an IGHMBP2 mutation is known, parents, siblings, or other at-risk relatives can be tested to see if they carry the mutation. This helps with family planning and early diagnosis, even before symptoms appear. Charcot-Marie-Tooth Association+2Northwestern Medicine+2Nerve biopsy (usually sural nerve)
In uncertain or research situations, a small cut of a sensory nerve in the leg (often the sural nerve) is taken and examined under a microscope. In axonal CMT like CMT2S, the biopsy may show loss of axons and secondary myelin changes, supporting the diagnosis, though genetic testing is preferred today. Semantic Scholar+2MDPI+2Muscle biopsy
Sometimes a muscle sample is examined to distinguish neurogenic (nerve-related) from muscle-based diseases. In CMT2S, muscle biopsy typically shows patterns of denervation and re-innervation, meaning muscle fibers have lost and partly regained nerve supply. Semantic Scholar+1Metabolic and toxic screening
In complex cases, tests for heavy metals, alcohol markers, or other toxins may be done to exclude acquired neuropathies. Finding no toxic or metabolic cause supports the role of a genetic factor such as IGHMBP2 mutation. Hospital for Special Surgery+2Cleveland Clinic+2
Electrodiagnostic tests
Nerve conduction studies (NCS)
Nerve conduction studies measure how fast and how strongly electrical signals travel along the nerves. In CMT2S, conduction speeds are usually near normal or only mildly slowed, but the signal size (amplitude) is reduced because axons are lost. This pattern is typical of axonal CMT (type 2). MDPI+2Muscular Dystrophy Association+2Electromyography (EMG)
EMG uses a needle electrode placed in muscles to record electrical activity. In CMT2S, EMG often shows signs of chronic denervation and re-innervation, such as large, long-duration motor unit potentials, confirming that the main problem lies in the peripheral nerves, not the muscle itself. MDPI+2Semantic Scholar+2Somatosensory evoked potentials (SSEPs)
SSEPs record brain responses to small electrical stimuli applied to peripheral nerves. They can show slowed or reduced signals along sensory pathways. While not always needed, they can support the presence of a sensory neuropathy affecting long pathways from limbs to brain. MDPI+2Hopkins Medicine+2
Imaging tests
X-rays of feet, ankles, and spine
Plain X-rays show structural deformities such as high-arched feet, hammertoes, ankle instability, and scoliosis. These images help orthopedic planning and document the skeletal consequences of long-standing neuropathy in CMT2S. nhs.uk+2MalaCards+2MRI of spine or peripheral nerves
MRI may be used to rule out other causes of weakness, such as spinal cord compression, and to study muscles and nerves. In some centers, MR neurography can show thinning or signal changes in peripheral nerves, complementing electrodiagnostic and genetic findings in CMT2S. Northwestern Medicine+2MDPI+2
Non-pharmacological treatments
Individualized physical therapy program
A neurologic physical therapist teaches safe exercises to keep muscles strong and joints flexible in CMT2S. The therapist usually focuses on the ankles, feet, hands, and core muscles. Gentle strengthening with low weight and many repetitions, plus stretching, can slow stiffness and help walking and balance. Studies in people with Charcot-Marie-Tooth disease show that supervised exercise can improve strength and function without making nerve damage worse when done carefully.Taylor & Francis Online+2PMC+2Occupational therapy for hand and daily tasks
Occupational therapists help people with CMT2S adapt daily activities like writing, buttoning clothes, using a phone, or typing. They may suggest larger pens, special keyboards, elastic shoelaces, and kitchen aids. The purpose is to protect hand joints, reduce fatigue, and keep independence at school, work, and home. Good occupational therapy can lower frustration and improve confidence in daily life.PMCStretching and contracture prevention
Because weak muscles and tight tendons can freeze joints in bad positions, a daily stretching routine is important. Simple ankle, calf, hamstring, and hand stretches are held slowly, not bounced, and repeated every day. The goal is to prevent “contractures,” where the joint cannot fully straighten, and to reduce pain and cramps. Stretching supports later use of braces and helps surgeries work better.PMC+1Low-impact strengthening exercises
Low-impact strengthening uses light resistance bands, water exercises, or body-weight exercises like sit-to-stand. The aim is to maintain muscle power without over-working damaged nerves. Exercise programs for CMT suggest training several times per week, watching carefully for pain and long-lasting fatigue after sessions. If symptoms flare for more than 48 hours, the program is usually adjusted.Taylor & Francis Online+1Aerobic (cardio) training
Gentle cycling, swimming, or treadmill walking can improve heart and lung fitness and reduce fatigue. For CMT, experts usually suggest moderate effort where talking is possible but singing is hard. Short sessions, such as 10–20 minutes, can be built up slowly. Better aerobic fitness helps with weight control, improves mood, and may make daily walking and climbing stairs easier.PMC+1Balance and gait training
Many people with CMT2S have unstable ankles, foot drop, and sensory loss, which increase falls. Balance exercises may include standing on different surfaces, stepping over obstacles, and practicing turning safely. Gait training teaches how to walk with braces, sticks, or a walker. The purpose is to lower fall risk and to make walking more energy-efficient, so the person can walk farther with less effort.PMC+1Orthotic devices (AFOs and splints)
Ankle–foot orthoses (AFOs) are light plastic or carbon fiber braces that hold the foot up and stabilize the ankle. Hand and wrist splints can support weak fingers and improve grip. Orthoses do not fix the nerve damage but can dramatically improve walking, reduce falls, and delay deformities. Orthotists usually adjust the devices regularly as the person grows or the deformity changes.PMC+1Custom footwear and insoles
People with CMT2S often have high arches and clawed toes. Special shoes with wide toe boxes, soft uppers, rockered soles, and custom insoles spread pressure across the foot and reduce calluses and pain. The purpose is to protect skin, improve comfort, and work together with braces and surgery. Good footwear can delay ulcers and reduce the risk of infection or amputation later in life.Assistive walking devices
Canes, crutches, or walkers may be used when weakness and balance problems are more severe. These devices widen the base of support and reduce the chance of falls. For longer distances, a manual or power wheelchair can preserve energy and allow participation in school, work, travel, and social life. Using a wheelchair is not a failure; it is a tool to increase freedom and safety.PMC+1Respiratory physiotherapy and monitoring
In some CMT2S cases, the diaphragm and breathing muscles can weaken. Regular checks of breathing function and cough strength allow early support. Respiratory therapists teach breathing exercises, devices to help clear mucus, and postural changes to ease breathing. The goal is to prevent chest infections and, if needed, plan non-invasive ventilation early rather than in an emergency.Frontiers+1Pain psychology and cognitive-behavioral therapy (CBT)
Chronic neuropathic pain and fatigue can lead to low mood, anxiety, and sleep problems. CBT uses simple tools to change negative thought patterns, improve coping skills, and build pacing strategies. Relaxation, mindfulness, and distraction techniques can reduce perceived pain and medication use. This therapy does not say “it is all in your head”; it adds mental tools alongside physical care.PMC+1Vocational and school rehabilitation
Rehabilitation teams can advise about suitable jobs, school accommodations, and adaptive devices for computer use or manual tasks. The purpose is to match the person’s abilities with the demands of the work or classroom, avoiding over-strain and repetitive injury. With proper support, many people with CMT2S can study and work successfully.PMCHome and environment modification
Simple changes such as removing loose rugs, adding grab bars in bathrooms, using non-slip mats, improving lighting, and installing handrails reduce accidents. In advanced disease, stair lifts, adjustable beds, and adapted bathrooms can keep a person safe at home and delay or prevent the need for institutional care.PMC+1Weight management and nutrition counseling
Extra body weight makes walking harder and increases stress on weak ankles, knees, and hips. A dietitian can help create a balanced meal plan to keep a healthy weight, protect heart health, and ensure enough vitamins such as B12 and D, which are important for nerves and bones. Good nutrition also supports immune function and wound healing.Cleveland Clinic+1Fatigue management and energy conservation
CMT2S can cause severe fatigue. Occupational therapists teach “pacing,” where tasks are broken into smaller chunks with rest breaks. People learn to prioritize important activities, use labor-saving tools, and sit instead of stand when possible. This strategy helps avoid crashes after over-activity and may keep someone active more consistently over the week.PMCMental health counseling and peer support
Living with a chronic genetic disease can lead to sadness, anger, or feeling alone. Psychologists, social workers, and support groups allow people to share worries, learn coping strategies, and reduce stigma. Good mental health care is associated with better adherence to exercise, brace use, and medical follow-up.PMC+1Genetic counseling and family planning
Because CMT2S is usually inherited in an autosomal recessive pattern, parents, siblings, and future children may carry the IGHMBP2 mutation. A genetic counselor explains inheritance, the chance of affected children, carrier testing, and prenatal or pre-implantation options. This support helps families make informed decisions and reduces guilt or blame.Frontiers+1Education about disease and self-care
Clear information in simple language about CMT2S, its prognosis, and realistic expectations reduces fear and confusion. Education includes warning signs of complications, safe activity levels, and drug or lifestyle risks. Knowledge empowers patients and caregivers and makes it easier to work as equal partners with the medical team.PMC+1Participation in clinical trials and registries
For rare conditions like CMT2S, joining patient registries and suitable clinical trials helps push research forward and sometimes offers access to new therapies. Trials are carefully monitored and follow strict safety rules. Families should discuss risks and potential benefits with their neurologist before joining a study.MDPI+2Charcot-Marie-Tooth Association+2Spiritual or cultural support
Many people find comfort in spiritual, religious, or cultural practices. While these approaches do not change the nerve damage, they can provide meaning, hope, and a sense of community. When combined with medical care, this emotional strength can improve quality of life and resilience.PMC
Drug treatments
At present, no medicine is approved specifically to cure or stop Charcot-Marie-Tooth neuropathy type 2S. Drug treatment focuses on controlling neuropathic pain, cramps, mood symptoms, and sleep problems, using medicines that are approved for other neuropathic conditions like diabetic peripheral neuropathy.ScienceDirect+2MDPI+2
Typical dose ranges below are from FDA labels for other neuropathic pain disorders and are examples only; your doctor may use different doses or decide that a drug is not suitable for you.FDA Access Data+4FDA Access Data+4FDA Access Data+4
Gabapentin
Gabapentin is an anti-seizure medicine widely used for neuropathic pain. It calms over-active nerve firing in the spinal cord and brain, which can reduce burning, stabbing, or shooting pain. For neuropathic pain, labels describe total daily doses up to about 1800–3600 mg, split into three doses; however, doctors usually start much lower and increase slowly to avoid dizziness and sleepiness. Common side effects are drowsiness, weight gain, swelling in the legs, and trouble thinking clearly.FDA Access Data+2FDA Access Data+2Pregabalin
Pregabalin (Lyrica) works on calcium channels in nerve cells to lower the release of pain-signaling chemicals. FDA labeling for neuropathic pain gives usual doses around 150–450 mg per day in divided doses, with some indications using up to 600 mg per day. Doctors usually start low, such as 50–75 mg at night, and adjust. Side effects include dizziness, sleepiness, swollen ankles, weight gain, and sometimes blurry vision or trouble concentrating.FDA Access Data+4FDA Access Data+4FDA Access Data+4Duloxetine
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant approved for diabetic peripheral neuropathic pain. It increases certain brain chemicals that modulate pain pathways. For neuropathic pain, FDA labeling recommends 60 mg once daily; higher doses are usually not more effective but cause more side effects. Typical side effects are nausea, dry mouth, tiredness, sweating, and sometimes increased blood pressure or mood changes.FDA Access Data+4FDA Access Data+4FDA Access Data+4Amitriptyline
Amitriptyline is an older tricyclic antidepressant commonly used at low doses at night for nerve pain and poor sleep. It blocks reuptake of serotonin and norepinephrine and also has sedating and anticholinergic effects. Neuropathic pain doses are often 10–75 mg at bedtime, titrated by the doctor. Side effects can include dry mouth, constipation, blurred vision, drowsiness, and in some people heart rhythm changes, so ECG checks may be needed.Cochrane+1Nortriptyline
Nortriptyline is similar to amitriptyline but may have slightly fewer sedating and anticholinergic effects. It is used off-label for neuropathic pain, usually starting around 10–25 mg at night and slowly increasing as tolerated. It shares similar side effects and heart-rhythm cautions, so it must be used carefully, especially with other medicines that affect the heart.CochraneVenlafaxine or other SNRIs
Venlafaxine and some other SNRIs can help neuropathic pain and depression at the same time. They work by boosting serotonin and norepinephrine signaling in the central nervous system. Doses for pain are usually in the same range as for depression and must be increased slowly. Side effects may include nausea, insomnia, sweating, raised blood pressure, and withdrawal symptoms if stopped suddenly.Cochrane+1Topical lidocaine patch
Lidocaine 5% patches can be applied to small painful areas such as the dorsum of the foot. They block sodium channels in the skin nerves, reducing local pain signals without causing much systemic effect. The patch is usually placed for up to 12 hours in 24 hours, on intact skin only. Skin irritation, redness, or mild numbness are the most common side effects.nhs.uk+1Topical capsaicin
Capsaicin creams or high-dose patches reduce substance P and other pain chemicals in pain fibers. After an early burning sensation, the nerve endings can become less sensitive for weeks or months. In practice, this may reduce burning pain in the feet. The main side effect is strong local burning and redness, so it must be applied under guidance and kept away from eyes and sensitive skin.Cochrane+1Non-steroidal anti-inflammatory drugs (NSAIDs)
Ibuprofen, naproxen, and similar drugs mainly help musculoskeletal pain from joint strain, tendonitis, or surgery, rather than neuropathic burning pain. They can still be useful when foot deformities cause secondary mechanical pain. NSAIDs must be used at the lowest effective dose and shortest time because of risks to the stomach, kidneys, and heart, especially in older adults.nhs.ukParacetamol (acetaminophen)
Paracetamol is often tried first for mild pain because it does not irritate the stomach like NSAIDs. It does not directly treat nerve pain but can reduce background aches and enhance the effect of other medicines. The total daily dose must stay below the limit set by local guidelines (often 3–4 g/day for adults) to avoid liver injury, and lower limits are used in people with liver disease or in children.nhs.ukMuscle relaxants such as baclofen or tizanidine
If CMT2S causes painful muscle spasms or stiffness, a doctor may use baclofen or tizanidine. These drugs act in the spinal cord to reduce muscle tone. They are usually taken several times per day at low starting doses. Side effects include sleepiness, dizziness, and weakness, so they must be introduced slowly and not stopped abruptly.PMCMood and sleep medicines (for associated symptoms)
Some people with CMT2S may need antidepressants (such as SSRIs) or sleep medicines for anxiety, depression, or severe insomnia related to chronic disease and pain. These drugs do not treat the neuropathy itself, but they can improve overall function and quality of life when used carefully under supervision, with attention to interactions with pain medicines.PMC+1
Because your request asks for 20 separate drugs specifically for CMT2S, it is important to be honest: current scientific reviews state that there is no proven disease-modifying drug therapy for any CMT type, including CMT2S; all medicines are symptom-based and often off-label.Cochrane+3ScienceDirect+3MDPI+3
Dietary molecular supplements
Evidence for supplements in CMT2S is limited, but some nutrients have been studied in other neuropathies. Always discuss doses with your doctor, especially if you are a teenager, pregnant, or taking other medicines.
Alpha-lipoic acid (ALA)
Alpha-lipoic acid is an antioxidant that works inside mitochondria. Studies in diabetic neuropathy show that oral ALA (commonly 600 mg per day in adults) can reduce burning pain and improve nerve conduction in some patients, likely by lowering oxidative stress and improving blood flow in nerves.explorationpub.com+4PubMed+4ClinicalTrials.gov+4Acetyl-L-carnitine (ALC)
Acetyl-L-carnitine helps move fatty acids into mitochondria for energy and may support nerve repair. Randomized trials in peripheral neuropathy suggest that daily doses (often 1000–3000 mg in adults, split during the day) can reduce pain and support nerve regeneration with a good safety profile. It may be especially helpful when neuropathy is linked to certain medicines or metabolic problems.ScienceDirect+4PMC+4PLOS+4Vitamin B12 (cobalamin)
Vitamin B12 is critical for myelin and DNA synthesis in nerves. Deficiency can itself cause severe neuropathy, and treatment with injections or high-dose tablets can reverse symptoms if given early. For people with CMT2S, checking and correcting B12 levels helps avoid extra damage on top of the genetic neuropathy. Typical replacement doses for deficiency are much higher than standard multivitamin doses and must be set by a doctor.AAFP+4Cleveland Clinic+4PubMed+4Vitamin D
Vitamin D supports bone health, muscle strength, and immune function. Low vitamin D is common in people with limited mobility or low sun exposure and can worsen muscle weakness and falls. Supplement doses depend on blood levels, age, and local guidelines. Correcting deficiency may improve overall strength and reduce fracture risk in CMT2S.Cleveland Clinic+1Omega-3 fatty acids (EPA and DHA)
Omega-3s from fish oil or algae have anti-inflammatory and membrane-stabilizing effects. Some studies in nerve injury and metabolic disease suggest they may support nerve repair and reduce inflammation. Typical doses are in the range of 500–2000 mg/day of combined EPA/DHA, but they can increase bleeding risk at high doses, especially with blood-thinning medicine.nhs.uk+1B-complex vitamins (B1, B6 in safe doses)
Thiamine (B1) and pyridoxine (B6) are important for nerve metabolism. Severe deficiency can cause neuropathy, while replacement can reverse it. However, very high doses of B6 over long periods can itself cause nerve damage, so balanced B-complex products and medical supervision are important. The mechanism involves supporting energy production and neurotransmitter synthesis in peripheral nerves.Cleveland Clinic+2nhs.uk+2Magnesium
Magnesium plays a role in nerve conduction and muscle relaxation. Some people with neuropathic pain or muscle cramps feel better when mild magnesium deficiency is corrected through diet or supplements. Excess magnesium can cause diarrhea or, at high levels, heart and breathing problems, so dosing must follow medical advice, especially in kidney disease.Verywell Health+1Coenzyme Q10 (CoQ10)
CoQ10 is part of the mitochondrial electron transport chain and has antioxidant effects. Small studies in mitochondrial and neuromuscular disorders show possible benefits in fatigue and exercise tolerance. Typical adult doses range from 100–300 mg/day. It is usually well tolerated but can interact with blood thinners like warfarin.PMC+1Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant properties and may modulate cellular stress pathways like the unfolded protein response, which are implicated in some CMT models. Most human neuropathy data are early and use doses of several hundred milligrams of standardized extract. It is often taken with black pepper extract to improve absorption but can upset the stomach in some people.explorationpub.comL-serine or other amino acids (research level)
In some hereditary neuropathies, abnormal toxic lipids can be reduced by high-dose L-serine supplementation, and this is being studied in CMT-like conditions. This is still experimental and not standard care for CMT2S, but it shows how diet-related molecules may one day modify nerve disease. Any amino-acid therapy should only be taken inside a controlled clinical trial.
Immunity-booster, regenerative and stem-cell-related drugs
Right now, there are no approved “stem cell drugs” or regenerative medicines specifically for CMT2S. Research is active, so this section explains approaches rather than giving normal doses (because they are not yet routine medicines).MDPI+1
Gene therapy replacing IGHMBP2
Scientists are developing viral vectors (often adeno-associated virus, AAV) to deliver a normal copy of the IGHMBP2 gene to motor and sensory neurons. In animal models of related IGHMBP2 diseases, gene replacement has improved survival and motor function. For CMT2S, these strategies are still in preclinical or very early trial stages, so there is no standard dose or schedule yet.Frontiers+1Antisense oligonucleotide (ASO) therapy
ASOs are short pieces of synthetic genetic material that can correct splicing or reduce toxic RNA. A recent personalized ASO was reported for a patient with IGHMBP2-related disease, and similar approaches may be used for CMT2S in the future. These therapies are given by injection into the spinal fluid and are highly specialized.Frontiers+1Small-molecule IGHMBP2 modulators (e.g., VCA-894A)
Vanda Pharmaceuticals is developing a small-molecule therapy, VCA-894A, targeted for CMT2S. An Investigational New Drug (IND) application has been accepted, and clinical trials are planned, but the drug is not approved, and no public standard dosing information exists yet. Families may be able to join trials through specialist centers.Charcot-Marie-Tooth Association+1Neurotrophic factors (e.g., NT-3 and others)
Neurotrophin-3 and similar growth factors support survival and growth of peripheral nerves. Experimental gene therapy using NT-3 has shown benefit in some CMT models, improving myelination and nerve conduction. Delivery systems and long-term safety are still under study, so this is not a regular treatment yet.Cell-based therapies (stem cells)
Researchers are testing mesenchymal stem cells and other cell types to release helpful growth factors or to support nerve repair in peripheral neuropathy models. So far, there is not enough high-quality evidence to recommend stem cell injections for CMT2S outside of approved clinical trials. Risks include immune reactions, tumor growth, and infections when done without strict controls.MDPIImmune-modulating support like vaccines and infection control
Although CMT2S is not an autoimmune disease, keeping the immune system strong is important. Recommended vaccines (such as flu and pneumonia vaccines) reduce serious infections that can weaken already fragile breathing and walking muscles. This is not a “regenerative drug,” but it helps protect overall health and prevents setbacks that can undo months of rehabilitation progress.PMC+1
Surgeries
Soft-tissue tendon lengthening
Tight Achilles tendons and plantar fascia can pull the foot into a tip-toe or high-arch position. Surgeons can carefully lengthen these structures to allow the heel to come down and the foot to sit flatter in the shoe. This can make brace fitting easier, reduce pain, and improve walking pattern and balance.PMC+1Tendon transfer surgery
In tendon transfer, a stronger working tendon is moved to replace the function of a weak or paralyzed muscle, such as lifting the front of the foot. The goal is to correct foot drop, improve push-off, and reduce tripping. This surgery often works best when done before joints become stiff and when combined with physical therapy and bracing.PMCFoot reconstruction and joint fusion (arthrodesis)
Severe cavovarus deformity (high arch and inward-turning heel) may need bone cuts and joint fusion to create a more stable foot. The purpose is to produce a plantigrade foot that fits in a flat shoe and brace, reducing pain and calluses. Recovery is long and usually involves casting and rehabilitation.Springer LinkSpine surgery for scoliosis or deformity
Some people with CMT develop scoliosis or kyphosis. When curves are large or progressing, spine surgery may be needed to prevent lung restriction, pain, and further deformity. This surgery stabilizes the spine with rods and screws and is considered only after careful assessment by a multidisciplinary team.PMCDiaphragm or respiratory support procedures
In rare CMT2S cases with diaphragm weakness, procedures like diaphragm plication or tracheostomy with long-term ventilation may be considered. These are major operations used only when non-surgical options are not enough. The aim is to stabilize breathing, reduce hospital admissions, and improve survival and comfort.Frontiers+1
Prevention and risk-reduction strategies
Because CMT2S is genetic, you cannot prevent the basic cause, but you can reduce complications:
Avoid drugs known to be toxic to peripheral nerves where possible (for example, certain chemotherapy drugs) under medical guidance.
Keep a healthy body weight to reduce stress on weak muscles and joints.
Do regular safe exercise to maintain strength, flexibility, and cardiovascular health.
Protect your feet with proper shoes, daily skin checks, and early treatment of blisters or sores.
Reduce fall risk by using braces, sticks, or walkers as advised and by modifying the home environment.
Keep vaccinations up to date to prevent serious chest infections.
Treat other conditions such as diabetes, vitamin deficiencies, and thyroid disease that can further damage nerves.
Avoid smoking and limit alcohol, as both can worsen neuropathy and circulation.
Attend regular follow-up with a neuromuscular clinic to detect problems with breathing, scoliosis, or severe deformities early.
Use genetic counseling to understand family risk and plan pregnancies with full information.Frontiers+3PMC+3Springer Link+3
When to see doctors urgently or regularly
You should have regular planned visits with a neurologist, rehabilitation team, and orthopedist for CMT2S, usually at least once or twice per year, or more often in childhood growth phases.
Contact a doctor urgently or go to emergency care if you notice:
Sudden worsening of weakness, new trouble walking, or many new falls.
New breathing problems, such as shortness of breath when lying flat, morning headaches, or daytime sleepiness.
Rapidly increasing back or neck pain, loss of bladder or bowel control, or sharp spine pain.
New severe foot wounds, redness spreading up the leg, fever, or signs of infection.
Strong mood changes, thoughts of hopelessness, or any feeling that you might harm yourself or others (this always needs immediate, caring help from adults and professionals).
If you are unsure whether a symptom is serious, it is safer to contact your doctor, emergency service, or local health hotline for advice.PMC+1
What to eat and what to avoid
For CMT2S, there is no special miracle diet, but a nerve-friendly, heart-healthy eating pattern helps your whole body cope better.
Eat plenty of colorful vegetables and fruits for antioxidants and fiber.
Choose whole grains (brown rice, oats, whole-wheat bread) instead of refined white grains.
Include lean protein such as fish, skinless poultry, beans, lentils, tofu, and eggs to support muscle maintenance.
Use healthy fats like olive oil, nuts, seeds, and avocado; fatty fish such as salmon or sardines provide omega-3 fats that may support nerve health.nhs.uk+1
Ensure enough vitamin-rich foods: dairy or fortified plant milks for calcium and vitamin D; meat, eggs, or fortified foods for vitamin B12, or supplements if you are vegetarian or vegan.Cleveland Clinic+1
Try to limit or avoid:
Very sugary drinks and sweets that cause weight gain and blood sugar spikes.
Large amounts of alcohol, which can directly damage nerves and worsen balance.
Highly processed foods high in salt and trans-fats, which raise heart and vessel risk.
Extreme fad diets that cut out whole food groups, as they can cause vitamin and mineral gaps.
Unregulated “nerve cure” products from the internet; these may be fake, contaminated, or interact with your medicines. Always ask your doctor before starting anything new.nhs.uk+2WebMD+2
Frequently asked questions
Is Charcot-Marie-Tooth neuropathy type 2S curable?
No. At present, CMT2S cannot be cured. Treatment focuses on managing symptoms, preventing complications, and supporting daily function with therapies, braces, and sometimes surgery. Research into gene therapy and targeted drugs is active and gives hope for future disease-modifying treatments.Cell+3ScienceDirect+3MDPI+3Can exercise make CMT2S worse?
Well-planned, moderate exercise designed by a therapist is usually safe and can improve strength and function. Over-training, heavy weight-lifting, or ignoring pain and fatigue may cause overuse injuries. The rule is “start low, go slow, and never push through severe pain.”Taylor & Francis Online+2Wiley Online Library+2Do braces mean I will end up in a wheelchair?
No. Braces like AFOs are tools to keep you walking safely for longer. They can delay joint damage and falls. Some people will still need a wheelchair later for long distances, but this is about saving energy and staying active, not giving up.PMC+1Will my children definitely have CMT2S?
CMT2S is usually autosomal recessive, meaning both parents must carry a faulty IGHMBP2 gene for a child to be affected. A genetic counselor can calculate the exact risk for your family and discuss carrier testing and reproductive options.Frontiers+2National Organization for Rare Disorders+2Can vitamins or supplements cure my neuropathy?
Supplements can help if you have a deficiency (for example, vitamin B12 or vitamin D) or may modestly reduce pain in some neuropathies (alpha-lipoic acid, acetyl-L-carnitine). They cannot fix the genetic cause of CMT2S. They should be used as part of a full treatment plan, not instead of medical care.Diabetes Journals+4PubMed+4PMC+4Is surgery always needed for foot problems?
No. Many people do well with good shoes, orthoses, and therapy alone. Surgery is considered when deformity is severe, braces no longer work well, or pain and calluses are not controlled. Decisions are made together with an experienced orthopedic surgeon and the rehabilitation team.Springer LinkCan CMT2S affect my breathing?
Some people with IGHMBP2-related disease mainly have spinal muscular atrophy with early, severe breathing problems; CMT2S usually has milder or later respiratory involvement, but diaphragm weakness has been reported. Regular breathing tests and watching for symptoms like morning headaches or shortness of breath are important.Frontiers+2IJ Case Reports and Images+2Is CMT2S the same as other Charcot-Marie-Tooth types?
CMT2S is one subtype of CMT2, which is the axonal group of Charcot-Marie-Tooth disease. All CMT types share distal weakness and sensory loss, but they differ in which gene is affected, the pattern of inheritance, age of onset, and severity. Knowing the exact type helps with prognosis and research trial eligibility.CMT Research Foundation+2Charcot-Marie-Tooth Association+2Can children with CMT2S play sports?
Many children can join non-contact, low-impact sports such as swimming, cycling, and some team games with adaptations. Activities that involve high risk of ankle injury or falls, such as aggressive contact sports or jumping from heights, may need to be limited. A therapist and doctor can give personalized advice.PMC+1Will my CMT2S stop getting worse at some point?
Most studies of CMT show slow progression over many years. The rate can vary between people and across life stages. Good management of weight, activity, and complications may help keep abilities stable for longer, but the underlying nerve problem usually does not fully stop.JAMA Network+1Are there special shoes for CMT2S?
Yes. Orthopedic shoes with stiff soles, extra depth, wide toe boxes, and cushioning can protect high arches and claw toes and can hold braces securely. A podiatrist or orthotist can help choose the best design for your foot shape and walking pattern.PMCCan CMT2S affect my hands and fine movements?
Yes. Although symptoms often start in the feet, many people later develop weakness and wasting in the hands, leading to difficulty with fine tasks like writing, buttoning, or using tools. Occupational therapy, splints, and adaptive devices can help protect function.PMC+2Charcot-Marie-Tooth Association+2Is CMT2S life-shortening?
For many people, CMT2S mainly affects limbs and does not greatly shorten life, especially with good respiratory and orthopedic care. However, severe cases with breathing involvement can be more serious. Early diagnosis, regular follow-up, infection prevention, and timely respiratory support help improve long-term outcomes.Frontiers+2Charcot-Marie-Tooth Association+2Can I take part in research for CMT2S?
Yes, research networks and foundations are actively searching for participants with IGHMBP2-related disease for natural history studies and early trials such as VCA-894A. Ask your neurologist or look at major CMT organizations’ websites for information about open studies.Charcot-Marie-Tooth Association+2MDPI+2What is the most important thing I can do right now?
The most important steps are to connect with a neuromuscular specialist team, follow a safe exercise and brace program, protect your feet and skin, maintain a healthy lifestyle, and seek emotional and social support. These actions cannot cure CMT2S but can strongly improve quality of life and independence.PMC+1
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
